Pexastimogene devacirepvec (Pexa-Vec; JX-594) is a cancer specific and transgene inserted oncolytic and immunotherapeutic vaccinia virus engineered to express human granulocyte-macrophage colony-stimulating factor (GM-CSF) and β-galactosidase. This evidence concerns the gene CSF2 and cancer.